Navigation Links
Gene find turns soldier beetle defence into biotech opportunity

New antibiotic and anti-cancer chemicals may one day be synthesised using biotechnology, following CSIRO's discovery of the three genes that combine to provide soldier beetles with their potent predator defence system.

CSIRO researchers, and a colleague at Sweden's Karolinska Institute, published details of the gene identification breakthrough and potential applications recently in the international journal Nature Communications.

"For the first time, our team has been able to isolate and replicate the three genes that combine to make the potent fatty acid that soldier beetles secrete to ward off predators and infection," said CSIRO Ecosystem Sciences research leader Dr Victoria Haritos.

"This discovery is important because it opens a new way for the unusual fatty acid to be synthesised for potential antibiotic, anti-cancer, or other industrial purposes," Dr Haritos said.

Soldier beetles exude a white viscous fluid from their glands to repel potential attacks from predators, as well as in a wax form to protect against infection.

The team found this fluid contains an exotic fatty acid called dihydromatricaria acid, or DHMA, which is one of a group called polyynes that have known anti-microbial and anti-cancer properties.

While DHMA and similar polyyne fatty acids are found in a wide variety of plants, fungi, liverworts, mosses, marine sponges and algae, these compounds have proved very difficult to manufacture using conventional chemical processes. However, Dr Haritos and her team have developed a way to achieve this.

"We have outlined a method for reproducing these polyyne chemicals in living organisms like yeast, using mild conditions" Dr Haritos said.

Soldier beetles are the only animals reported to contain DHMA. This, together with the observation that the beetles forage on plants (such as daisies) which contain a lot of these types of fatty acids, led to previous incorrect conclusions that the DHMA in soldier beetles was derived from their diet.

"Through our research and the gene differences we have discovered, we now know soldier beetles have evolved this same defensive compound entirely independently of its production in plants and fungi," Dr Haritos said.

Contact: Andrew Warren
CSIRO Australia

Related biology news :

1. How silver turns people blue
2. EyeLock Inc. Introduces EyeSwipe Nano TS Iris Scanning Turnstile Solution for Secure Access Control
3. NTUs new loo turns poo into power
4. Commonly used pesticide turns honey bees into picky eaters
5. New research about facial recognition turns common wisdom on its head
6. WPI receives $1.9 million from US Army to develop sensors that can save wounded soldiers
7. Harvards Wyss Institute to develop smart suit that improves soldiers physical endurance
8. Kinesiology team gets $975,000 Defense grant to study effects of heavy loads on soldiers
9. Drought in 2001-2002 fueled Rocky Mountain pine beetle outbreak
10. 2001-2002 drought helped propel mountain pine beetle epidemic, says CU study
11. Size does matter in sexual selection, at least among beetles
Post Your Comments:
Related Image:
Gene find turns soldier beetle defence into biotech opportunity
(Date:11/17/2015)... November 17, 2015 Paris ... 2015.  --> Paris , qui ... DERMALOG, le leader de l,innovation biométrique, a inventé ... passeports et empreintes sur la même surface de balayage. ... et l,autre pour les empreintes digitales. Désormais, un seul ...
(Date:11/12/2015)... Nov. 12, 2015  A golden retriever that stayed ... dystrophy (DMD) has provided a new lead for treating ... the Broad Institute of MIT and Harvard and the ... . Cell, pinpoints a protective ... the disease,s effects. The Boston Children,s lab of ...
(Date:11/10/2015)... , Nov. 10, 2015  In this ... the basis of product, type, application, disease ... in this report are consumables, services, software. ... are safety biomarkers, efficacy biomarkers, and validation ... report are diagnostics development, drug discovery and ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... SAN DIEGO , Nov. 25, 2015  Neurocrine ... Kevin Gorman , President and CEO of Neurocrine ... Jaffray Healthcare Conference in New York ... encouraged to visit the website approximately 5 minutes prior ... software.  A replay of the presentation will be available ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... featured on AngelList early in their initial angel funding process. Now, they are ... individuals looking to make early stage investments in the microbiome space. In ...
(Date:11/24/2015)... 2015 /CNW/ - iCo Therapeutics ("iCo" or "the Company") ... for the quarter ended September 30, 2015. Amounts, ... and presented under International Financial Reporting Standards ("IFRS"). ... said Andrew Rae , President & CEO ... not only value enriching for this clinical program, ...
(Date:11/24/2015)... November 24, 2015 --> ... research report "Oligonucleotide Synthesis Market by Product & Services ... Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, ... MarketsandMarkets, the market is expected to reach USD 1,918.6 ... at a CAGR of 10.1% during the forecast period. ...
Breaking Biology Technology: